谷歌浏览器插件
订阅小程序
在清言上使用
VIPCreated with Sketch.
研究兴趣

论文共 212 篇作者统计合作学者相似作者

按年份排序按引用量排序主题筛选期刊级别筛选合作者筛选合作机构筛选
时间
引用量
主题
期刊级别
合作者
合作机构
Efficacy and Safety of Anti-Cd19 CAR-T in a Mouse Model of IgG4-related Disease
Yeting Sun, Sicheng Huang, Bo Zhang,Yu Peng, Hui Lu,Yimeng Jia,Ruijie Sun,Fenghua Zhang,Jiaxin Zhou,Linyi Peng,Mengtao Li,Wen Zhang,Yunyun Fei
INTERNATIONAL IMMUNOPHARMACOLOGY (2025)
引用0浏览0WOS引用
0
0
Elevated Eosinophil-to-lymphocyte Ratio (ELR) As a Predictor of Relapse for IgG4-related Disease: a Retrospective Study Across a Decade
Nianyi Zhang,Yu Peng, Rongli Li, Yuxue Nie, Jingna Li, Xinli Yang, Jialei Zhang, Yifei Wang, Qinhuan Luo,Jiaxin Zhou,Yunyun Fei,Mengtao Li,Linyi Peng,Wen Zhang
Clinical and Experimental Medicineno. 1 (2025): 1-11
引用0浏览0WOS引用
0
0
Comparisons of [68 Ga]Ga-FAPI-04 PET/CT with X-ray Imaging in the Assessment of Patients with Rheumatoid Arthritis
Dan Yang, Jiana Chen, Guangyuan He, Ziyue Zhou, Jiaqi Xu, Yezi Peng, Xiangyi Shen,Xu Jiang,Qingqing Pan,Lidan Zhao,Yunyun Fei,Yaping Luo,Huaxia Yang
Clinical Rheumatologyno. 6 (2025): 2191-2199
引用0浏览0WOS引用
0
0
Mortality and Survival Analysis in Patients with Cancer Occurrence after Sjogren's Syndrome: A Long-Term Cohort Study in China
Yezi Peng, Jiana Chen, Yafei Ren, Dan Yang, Ziyue Zhou,Xiangyi Shen, Junyan Qian,Xu Jiang,Lidan Zhao,Yunyun Fei,Hua Chen,Mengtao Li,Huaxia Yang,Fengchun Zhang
INTERNATIONAL JOURNAL OF RHEUMATIC DISEASESno. 1 (2025)
引用0浏览0WOS引用
0
0
Exploring the Clinical Characteristics and Long-Term Outcome of Serologically Active Clinically Quiescent IgG4-related Disease: Knowledge from a Prospective Cohort
Jingna Li, Yuxue Nie,Fei Teng,Linyi Peng, Jie Meng, Qinhuan Luo, Nianyi Zhang, Jialei Zhang, Xinli Yang, Yifei Wang,Yunyun Fei,Jiaxin Zhou,Wen Zhang
Clinical rheumatology (2025)
引用0浏览0WOS引用
0
0
加载更多
作者统计

#Papers: 211

#Citation: 4329

H-Index: 35

G-Index: 61

Sociability: 7

Diversity: 3

Activity: 42

  • 合作者
  • 学生
  • 导师
暂无相似学者，你可以通过学者研究领域进行搜索筛选
数据免责声明
页面数据均来自互联网公开来源、合作出版商和通过AI技术自动分析结果，我们不对页面数据的有效性、准确性、正确性、可靠性、完整性和及时性做出任何承诺和保证。若有疑问，可以通过电子邮件方式联系我们：report@aminer.cn